Zobrazeno 1 - 3
of 3
pro vyhledávání: '"RICCARDO RONGA"'
Autor:
Vito Longo, Carminia Maria Della Corte, Alessandro Russo, Francesca Spinnato, Francesca Ambrosio, Riccardo Ronga, Antonella Marchese, Teresa Del Giudice, Concetta Sergi, Francesca Casaluce, Marina Gilli, Michele Montrone, Valerio Gristina, Vincenzo Sforza, Maria Lucia Reale, Raimondo Di Liello, Alberto Servetto, Helga Lipari, Claudio Longhitano, Laura Vizzini, Anna Manzo, Antonella Cristofano, Loretta Paolelli, Annalisa Nardone, Simona De Summa, Antonella Perrone, Carmela Bisceglia, Caterina Derosa, Valerio Nardone, Giuseppe Viscardi, Domenico Galetta, Fabiana Vitiello
Publikováno v:
Frontiers in Immunology, Vol 14 (2024)
BackgroundConsolidative thoracic radiotherapy (TRT) has been commonly used in the management of extensive-stage small cell lung cancer (ES-SCLC). Nevertheless, phase III trials exploring first-line chemoimmunotherapy have excluded this treatment appr
Externí odkaz:
https://doaj.org/article/0916d9972ccf47d690c1cb596c1e055d
Autor:
Maria Giuseppa Vitale, Anna Crispo, Dario Arundine, Riccardo Ronga, Carmela Barbato, Assunta Luongo, Francesco Habetswallner, Bernardo Maria De Martino, Angela Maione, Sandra Eisenwagen, Giovanna Vitale, Ferdinando Riccardi
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Following the previously published results of the clinical randomized ZeOxaNMulti trial, we evaluated the potential of the tested product PMA-ZEO (Multizeo Med) in the prevention of chemotherapy-induced side effects (especially peripheral neuropathy)
Externí odkaz:
https://doaj.org/article/c4ca039d4289417693277ce6d9cd7067
Autor:
FRANCESCO JACOPO ROMANO, RICCARDO RONGA, FRANCESCA AMBROSIO, DARIO ARUNDINE, VITO LONGO, DOMENICO GALETTA, CESARE GRIDELLI, PAOLO MAIONE, VALENTINA PALMA, VINCENZO DAMIANO, ANTONIO VERDE, ILARIA GIACOBBE, MARIA ROSARIA AUGURIO, GENNARO IENGO, MASSIMILIANO CHETTA, MARINA TARSITANO, SEVERO CAMPIONE, GIUSEPPE FAILLA, ANTONIO RAUCCI, FERDINANDO RICCARDI
Publikováno v:
Cancer Diagn Progn
Background/Aim: Lung cancer is one of the most common malignant neoplastic diseases and by far the leading cause of cancer death worldwide. Recently, immune checkpoint inhibitors (ICIs) have received increasing attention for playing a crucial role in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f2d898c524d619bebe4c41b1a93261f
https://europepmc.org/articles/PMC9801444/
https://europepmc.org/articles/PMC9801444/